PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 1, 2007Seminars in Respiratory and Critical Care Medicine155 citations

Extrapulmonary Sarcoidosis

View Full Paper
MJMarc A. Judson

Key Points

  • To review the diverse clinical presentations and therapeutic management strategies for extrapulmonary sarcoidosis.
  • Narrative review of clinical evidence regarding multiorgan sarcoidosis presentations and treatment modalities.
  • Extrapulmonary involvement serves as a primary driver of major disease-related morbidity.
  • Effective disease management frequently requires alternative immunosuppressive agents, topical therapies, or interventions not specifically targeting granulomatous inflammation.

Abstract

Sarcoidosis can affect any organ in the body. Frequently extrapulmonary manifestations of the disease are the major cause of morbidity. Treatment of extrapulmonary sarcoidosis often requires consideration of alternative immunosuppressive agents, topical therapy, or therapy that is not specifically directed against the granulomatous inflammation of the disease. This article reviews the clinical presentation and therapy of extrapulmonary sarcoidosis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Marc A. Judson (2007) studied this question.

synapsesocial.com/papers/6a1d36da73c56dd1bd2f5ee3https://doi.org/10.1055/s-2007-970335
Ask AI
Helpful
Bookmark
Share
View Full Paper